标题
PARP inhibitors: polypharmacology versus selective inhibition
作者
关键词
-
出版物
FEBS Journal
Volume 280, Issue 15, Pages 3563-3575
出版商
Wiley
发表日期
2013-04-22
DOI
10.1111/febs.12298
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation
- (2013) Ruth Plummer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PARP inhibitors in cancer therapy: an update
- (2013) Gianluca Papeo et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Tankyrases as drug targets
- (2013) Lari Lehtiö et al. FEBS Journal
- Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies
- (2013) T. J. Gaymes et al. HAEMATOLOGICA
- Structural Basis and SAR for G007-LK, a Lead Stage 1,2,4-Triazole Based Specific Tankyrase 1/2 Inhibitor
- (2013) Andrew Voronkov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond
- (2013) Nicola J. Curtin et al. MOLECULAR ASPECTS OF MEDICINE
- Structural biology of the writers, readers, and erasers in mono- and poly(ADP-ribose) mediated signaling
- (2013) Tobias Karlberg et al. MOLECULAR ASPECTS OF MEDICINE
- Poly(ADP-ribose) signaling in cell death
- (2013) László Virág et al. MOLECULAR ASPECTS OF MEDICINE
- Identification of Pim Kinases as Novel Targets for PJ34 with Confounding Effects in PARP Biology
- (2012) Albert A. Antolín et al. ACS Chemical Biology
- Structure of human tankyrase 1 in complex with small-molecule inhibitors PJ34 and XAV939
- (2012) Christina A. Kirby et al. Acta Crystallographica Section F-Structural Biology and Crystallization Communications
- Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells
- (2012) Hsiao-Ching Chuang et al. BREAST CANCER RESEARCH AND TREATMENT
- Abstract 4688: E7449: A novel PARP inhibitor enhances the efficacy of radiotherapy and chemotherapy and has potent single agent anticancer activity in BRCA-deficient tumors
- (2012) Sharon McGonigle et al. CANCER RESEARCH
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- The Role of PARP-1 and PARP-2 Enzymes in Metabolic Regulation and Disease
- (2012) Péter Bai et al. Cell Metabolism
- Failure of Iniparib to Inhibit Poly(ADP-Ribose) Polymerase In Vitro
- (2012) A. G. Patel et al. CLINICAL CANCER RESEARCH
- Role of PARP Inhibitors in Cancer Biology and Therapy
- (2012) D. Davar et al. CURRENT MEDICINAL CHEMISTRY
- Targeting the DNA damage response in oncology
- (2012) Bristi Basu et al. CURRENT OPINION IN ONCOLOGY
- Discovery of Ligands for ADP-Ribosyltransferases via Docking-Based Virtual Screening
- (2012) C. David Andersson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Secondary mutations inBRCA2associated with clinical resistance to a PARP inhibitor
- (2012) Louise J Barber et al. JOURNAL OF PATHOLOGY
- The DNA damage response and cancer therapy
- (2012) Christopher J. Lord et al. NATURE
- Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors
- (2012) Elisabet Wahlberg et al. NATURE BIOTECHNOLOGY
- Tankyrase-targeted therapeutics: expanding opportunities in the PARP family
- (2012) Jenna L. Riffell et al. NATURE REVIEWS DRUG DISCOVERY
- New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
- (2012) Bryan A. Gibson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Unusual increase in lumbar network excitability of the rat spinal cord evoked by the PARP-1 inhibitor PJ-34 through inhibition of glutamate uptake
- (2012) Sara Ebrahimi Nasrabady et al. NEUROPHARMACOLOGY
- New readers and interpretations of poly(ADP-ribosyl)ation
- (2012) Thomas Kalisch et al. TRENDS IN BIOCHEMICAL SCIENCES
- Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors
- (2012) Janneke E. Jaspers et al. Cancer Discovery
- Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia
- (2011) Yasuhiro Egi et al. BRAIN RESEARCH
- MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model
- (2011) Shigeru Matsuura et al. BRAIN RESEARCH
- Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase
- (2011) F Moroni et al. BRITISH JOURNAL OF PHARMACOLOGY
- Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a Bona Fide PARP Inhibitor
- (2011) X. Liu et al. CLINICAL CANCER RESEARCH
- PARP-3 and APLF Function Together to Accelerate Nonhomologous End-Joining
- (2011) Stuart L. Rulten et al. MOLECULAR CELL
- Re-evaluating PARP1 inhibitor in cancer
- (2011) Alexei Tulin NATURE BIOTECHNOLOGY
- PARP inhibitors stumble in breast cancer
- (2011) Malini Guha NATURE BIOTECHNOLOGY
- Probing the links between in vitro potency, ADMET and physicochemical parameters
- (2011) M. Paul Gleeson et al. NATURE REVIEWS DRUG DISCOVERY
- Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression
- (2011) C. Boehler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A snapshot of chemoresistance to PARP inhibitors
- (2011) Alberto Chiarugi TRENDS IN PHARMACOLOGICAL SCIENCES
- Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ
- (2011) Roberto Pellicciari et al. MedChemComm
- A review of PARP inhibitors: from bench to bedside
- (2010) C. Underhill et al. ANNALS OF ONCOLOGY
- 6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance
- (2010) N. Issaeva et al. CANCER RESEARCH
- Rational approaches to targeted polypharmacology: creating and navigating protein–ligand interaction networks
- (2010) James T Metz et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Drug profiling: knowing where it hits
- (2010) Alejandro Merino et al. DRUG DISCOVERY TODAY
- Inhibition of matrix metalloproteinase-2 by PARP inhibitors
- (2009) Adrian C. Nicolescu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification of aminoethyl pyrrolo dihydroisoquinolinones as novel poly(ADP-ribose) polymerase-1 inhibitors
- (2009) Danila Branca et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage
- (2009) F Moroni et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Phase IB Trial of Intravenous INO-1001 Plus Oral Temozolomide in Subjects with Unresectable Stage-III or IV Melanoma
- (2009) Agop Y. Bedikian et al. CANCER INVESTIGATION
- In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016
- (2009) A. L. Russo et al. CLINICAL CANCER RESEARCH
- Structural Basis for Inhibitor Specificity in Human Poly(ADP-ribose) Polymerase-3†
- (2009) Lari Lehtiö et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors
- (2009) Philip Jones et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- Predicting new molecular targets for known drugs
- (2009) Michael J. Keiser et al. NATURE
- Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
- (2009) Baozhi Chen et al. Nature Chemical Biology
- Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites
- (2009) Matthias Altmeyer et al. NUCLEIC ACIDS RESEARCH
- Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease
- (2008) Pal Pacher et al. AMERICAN JOURNAL OF PATHOLOGY
- Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer
- (2008) Thomas D. Penning et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Phase 0 Trials: An Industry Perspective
- (2008) H. Eliopoulos et al. CLINICAL CANCER RESEARCH
- Preclinical Modeling of a Phase 0 Clinical Trial: Qualification of a Pharmacodynamic Assay of Poly (ADP-Ribose) Polymerase in Tumor Biopsies of Mouse Xenografts
- (2008) R. J. Kinders et al. CLINICAL CANCER RESEARCH
- Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors
- (2008) R. Plummer et al. CLINICAL CANCER RESEARCH
- 4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1
- (2008) Keith A. Menear et al. JOURNAL OF MEDICINAL CHEMISTRY
- A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial
- (2008) David A. Morrow et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
- (2008) Wataru Sakai et al. NATURE
- Data completeness—the Achilles heel of drug-target networks
- (2008) Jordi Mestres et al. NATURE BIOTECHNOLOGY
- Toward specific functions of poly(ADP-ribose) polymerase-2
- (2008) José Yélamos et al. TRENDS IN MOLECULAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now